• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 74 of 100
Herceptin Approved For Treatment Of Scottish Breast Cancer Patients
HealthHow Mylan Is Taking On One of the World’s Top Breast Cancer Drugs
By Sy MukherjeeJune 5, 2016
pancreatic cancer cell
TechStudy Finds Targeted Cancer Drugs May Work in Range of Tumor Types
By ReutersJune 4, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
HealthHere’s Why Worldwide Cancer Drug Spending Spiked Last Year
By Sy MukherjeeJune 2, 2016
Chicago skyscrapers
HealthWhat You Need to Know About the World’s Biggest Cancer Conference
By Sy MukherjeeJune 2, 2016
The Davos World Economic Forum 2015
HealthNovartis CEO on Why the Firm Just Opened a Major R&D Facility in China
By Scott CendrowskiJune 2, 2016
475158099
HealthSuperbugs: The $100 Trillion Risk
By Vikram MansharamaniJune 1, 2016
How One Asian Pharma Giant Wants to Make a Splash in the U.S.
HealthHow One Asian Pharma Giant Wants to Make a Splash in the U.S.
By Sy MukherjeeJune 1, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
FinancePharma Packager PCI Sells for More Than $1 Billion
By Dan PrimackJune 1, 2016
Carl Icahn Recently Bought a ‘Large Position’ in Allergan
FinanceCarl Icahn Recently Bought a ‘Large Position’ in Allergan
By Sy MukherjeeMay 31, 2016
Pills and capsules
HealthJazz Pharmaceuticals Is Buying Celator For $1.5 Billion
By ReutersMay 31, 2016
185759873
HealthNew Incentives Needed to Develop Antibiotics to Fight Superbugs
By ReutersMay 29, 2016
General Economy Images In Bangladesh
HealthIndia’s Sun Pharma Gets U.S. Subpoena Over Generic Drugs Pricing
By ReutersMay 28, 2016
A Monsanto logo is pictured in the company headquarters in Morges
LeadershipHow Four Words Rewrote Bayer-Monsanto Deal Script
By ReutersMay 28, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
HealthValeant Said to Have Rejected a Takeover Bid This Spring
By ReutersMay 27, 2016
The First Implant to Treat Opioid Addiction Just Got Approved
HealthThe First Implant to Treat Opioid Addiction Just Got Approved
By Sy MukherjeeMay 26, 2016
1...
  • 72
  • 73
  • 74
  • 75
  • 76
...100
Most Popular
Success
'Work hard, stay loyal, and the system will reward you': the Boomer credo is a Gen X betrayal and a Millennial pipe dreamplaceholder alt text
By Nick LichtenbergJune 16, 2026
Personal Finance
Current price of oil as of June 17, 2026placeholder alt text
By Joseph HostetlerJune 17, 2026
Big Tech
Hundreds of Stanford students walked out of their grad ceremony to protest Google CEO’s commencement speech. It wasn’t all about AIplaceholder alt text
By Tristan BoveJune 15, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.